TI
PLRX icon

Trexquant Investment’s Pliant Therapeutics PLRX Stock Holding History

Trexquant Investment’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-62,477
Closed -$823K – 1801
2024
Q4 		$823K Sell
62,477
-24,375
-28% -$333K 0.01% 1154
2024
Q3 		$974K Sell
86,852
-71,848
-45% -$899K 0.01% 1062
2024
Q2 		$1.71M Buy
+158,700
New +$2.05M 0.03% 807
2023
Q4 		– Sell
-42,277
Closed -$733K – 1711
2023
Q3 		$733K Buy
42,277
+22,308
+112% +$387K 0.02% 873
2023
Q2 		$362K Sell
19,969
-23,330
-54% -$552K 0.01% 1130
2023
Q1 		$1.15M Sell
43,299
-1,652
-4% -$47K 0.03% 680
2022
Q4 		$869K Buy
44,951
+8,331
+23% +$174K 0.02% 699
2022
Q3 		$765K Buy
36,620
+2,786
+8% +$53.3K 0.03% 633
2022
Q2 		$271K Sell
33,834
-8,170
-19% -$52.3K 0.01% 1180
2022
Q1 		$294K Buy
+42,004
New +$429K 0.01% 1019

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Trexquant Investment's PLRX Position: Q1 2025 in Review

Trexquant Investment sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 62,477 shares — an estimated $823K sold.

Trexquant Investment first reported a position in PLRX in Q1 2022 and held it in 10 quarters. The position peaked at $1.71M in Q2 2024. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Trexquant Investment reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 62,477 Pliant Therapeutics shares in Q1 2025, an estimated $823K.
  • Trexquant Investment first reported a position in Pliant Therapeutics in Q1 2022 and held it in 10 quarters.
  • Trexquant Investment's Pliant Therapeutics position peaked at $1.71M in Q2 2024.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.